Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The price of Rockwell Medical Inc (NASDAQ: RMTI) closed at $2.13 in the last session, down -2.29% from day before closing price of $2.18. In other words, the price has decreased by -$2.29 from its previous closing price. On the day, 0.6 million shares were traded. RMTI stock price reached its highest trading level at $2.2 during the session, while it also had its lowest trading level at $2.11.
Ratios:
We take a closer look at RMTI’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.68 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 25.57. For the most recent quarter (mrq), Quick Ratio is recorded 2.00 and its Current Ratio is at 2.41. In the meantime, Its Debt-to-Equity ratio is 0.49 whereas as Long-Term Debt/Eq ratio is at 0.40.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on November 14, 2024, initiated with a Buy rating and assigned the stock a target price of $5.
On June 24, 2019, Piper Jaffray started tracking the stock assigning a Overweight rating and target price of $10.
On May 13, 2019, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $11.H.C. Wainwright initiated its Buy rating on May 13, 2019, with a $11 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 15 ’24 when RAVICH MARK H sold 19,991 shares for $2.32 per share. The transaction valued at 46,379 led to the insider holds 0 shares of the business.
RAVICH MARK H sold 10,000 shares of RMTI for $24,000 on Nov 15 ’24. The Director now owns 121,429 shares after completing the transaction at $2.40 per share. On Oct 01 ’24, another insider, Chole Timothy, who serves as the SVP, Chief Commercial Officer of the company, sold 1,001 shares for $3.69 each. As a result, the insider received 3,689 and left with 55,171 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RMTI now has a Market Capitalization of 68839048 and an Enterprise Value of 90329520. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.68 while its Price-to-Book (P/B) ratio in mrq is 2.36. Its current Enterprise Value per Revenue stands at 0.957 whereas that against EBITDA is -102.067.
Stock Price History:
Over the past 52 weeks, RMTI has reached a high of $5.15, while it has fallen to a 52-week low of $1.16. The 50-Day Moving Average of the stock is -33.79%, while the 200-Day Moving Average is calculated to be -9.22%.
Shares Statistics:
According to the various share statistics, RMTI traded on average about 804.52K shares per day over the past 3-months and 692000 shares per day over the past 10 days. A total of 32.32M shares are outstanding, with a floating share count of 28.29M. Insiders hold about 12.46% of the company’s shares, while institutions hold 29.27% stake in the company. Shares short for RMTI as of 1728950400 were 823372 with a Short Ratio of 1.39, compared to 1726185600 on 397531. Therefore, it implies a Short% of Shares Outstanding of 823372 and a Short% of Float of 2.6700001.
